Metagenomic analysis of the gut microbiota in major depressive disorder with different antidepressant efficacy: A prospective cohort study
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.120709 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Jia-Yu Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: dujiayu1016@163.com. Hauptthemen laut MEDLINE: Major Depressive Disorder, Gastrointestinal Microbiome, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Sichuan University, Science and Technology Department of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Major depressive disorder (MDD) is globally prevalent, with Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) as first-line treatment. However, 30 %-40 % of patients have inadequate response, and early identification is difficult. Gut microbiota contributes to MDD pathogenesis through the gut-brain axis, but baseline differences between responders and non-responders to SSRIs or SNRIs remain unclear. METHODS: 82 MDD individuals were initially screened. However, due to issues with the drug administration and fecal sample availability, a total of 43 people were eventually included. Based on 3-month Hamilton Depression Rating Scale (HAMD-17) changes, 29 patients were responders (39.12 ± 15.79 years, 8 males), while 14 were non-responders (40.14 ± 17.28 years, 5 males). Baseline assessments encompassed Depression Anxiety scales, demographics, and fecal metagenomic analysis (taxonomic/functional annotation, and differential analysis of microbial species and pathways). RESULTS: Baseline demographic characteristics, lifestyle factors, and anxiety/depression scores were comparable. Non-responders had higher relative abundances of Bacteroidaceae and Bacteroide; LEfSe showed responders enriched Hungatella, Ligilactobacillus_ruminis, and non-responders enriched Anaerostipes, Bacteroides_faecis. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis identified 246 differentially expressed KEGG Orthologies and 13 pathways, with the steroid biosynthesis pathway (map00100) being enriched in non-responders and the D-amino acid metabolism pathway (map00470) enriched in responders. The study has limitations: small sample size and it lacks direct mechanism validation. CONCLUSIONS: The composition and functional pathways of gut microbiota exhibit significant differences between responders and non-responders to SSRIs or SNRIs among MDD patients, providing clues for the development of new treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: dujiayu1016@163.com.
- Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: fanglinq0723@163.com.
- Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: yara0816@163.com.
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China. Electronic address: chenyilong@scu.edu.cn.
- Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: guifengtan@126.com.
- Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: 1140164954@qq.com.
Förderung
- Sichuan University
- Science and Technology Department of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Du, J. Y., Qin, F. L., Yang, R. N., Chen, Y. L., Tan, G. F., Li, W. J., Yang, L., Cai, J., Shen, D. L., Zhu, H. R., Yuan, M. L., & Zhang, W. (2026). Metagenomic analysis of the gut microbiota in major depressive disorder with different antidepressant efficacy: A prospective cohort study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120709
Vancouver
Du JY, Qin FL, Yang RN, Chen YL, Tan GF, Li WJ, et al. Metagenomic analysis of the gut microbiota in major depressive disorder with different antidepressant efficacy: A prospective cohort study. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120709
BibTeX
@article{Du2026,
author = {Du, Jia-Yu and Qin, Fang-Lin and Yang, Run-Nan and Chen, Yi-Long and Tan, Gui-Feng and Li, Wen-Jing and Yang, Lin and Cai, Jia and Shen, Dan-Lin and Zhu, Hong-Ru and Yuan, Min-Lan and Zhang, Wei},
title = {Metagenomic analysis of the gut microbiota in major depressive disorder with different antidepressant efficacy: A prospective cohort study},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.120709}
}
EUVIMED